PolyPeptide Group AG (XSWX:PPGN) Long-Term Debt : CHF46.3 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is PolyPeptide Group AG Long-Term Debt?

PolyPeptide Group AG's Long-Term Debt for the quarter that ended in Dec. 2023 was CHF46.3 Mil.

PolyPeptide Group AG's quarterly Long-Term Debt stayed the same from Dec. 2022 (CHF0.0 Mil) to Jun. 2023 (CHF0.0 Mil) but then increased from Jun. 2023 (CHF0.0 Mil) to Dec. 2023 (CHF46.3 Mil).

PolyPeptide Group AG's annual Long-Term Debt stayed the same from Dec. 2021 (CHF0.0 Mil) to Dec. 2022 (CHF0.0 Mil) but then increased from Dec. 2022 (CHF0.0 Mil) to Dec. 2023 (CHF46.3 Mil).

PolyPeptide Group AG Long-Term Debt Historical Data

The historical data trend for PolyPeptide Group AG's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPeptide Group AG Long-Term Debt Chart

PolyPeptide Group AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

27.29

27.02

46.29

PolyPeptide Group AG Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Debt	Get a 7-Day Free Trial					-	-	-	-	46.29

PolyPeptide Group AG (XSWX:PPGN) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

PolyPeptide Group AG Long-Term Debt Related Terms

Thank you for viewing the detailed overview of PolyPeptide Group AG's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

PolyPeptide Group AG (XSWX:PPGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (XSWX:PPGN) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

PPGNz:UK

Address

Neuhofstrasse 24, Baar, Zug, CHE, 6340

Website

https://www.polypeptide.com

PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives a majority of its revenue from Europe and Asia.

PolyPeptide Group AG (XSWX:PPGN) Headlines

No Headlines